To validate the platform, we recapitulated findings from two previous studies examining WNT pathway alterations in high-risk CRC populations, including mutation prevalence in RNF43 and AXIN2 and survival outcomes associated with WNT pathway status across ethnic and age subgroups. The gene discussed is AXIN2; the disease is colorectal carcinoma.